Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

WuXi Biologics expects to receive EU GMP nod in matter of months

The EMA completes pre-approval inspection of WuXi Biologics facilities, raising no critical issues for the Chinese company.

ATS harnesses electromagnetic technology for cell minimizing unit

ATS’ SuperTrak Micro minimizes cell sizes through electromagnetic sorting while merging and diverting at full production speed.

European manufacturing waiver to ‘level the playing field’

The introduction of the SPC manufacturing waiver will generate billions in export sales and create a number of jobs across the EU, suggests Medicines for Europe.

Novartis doubles investment in AveXis North Carolina site

In addition to the $55m previously invested, Novartis will spend a further $60m in expanding AveXis’ site in North Carolina enabling the manufacture of multiple gene therapies simultaneously.

Four-pronged partnership to produce automated systems for CRISPR

Oxford Genetics and Sphere Fluidics to partner, alongside additional biopharma organizations, to develop automated systems for high-throughput gene editing in mammalian cell lines.